Most Recent
Debt collector fined $750k for harassing stroke victim, single mum
Debt collector ACM Group has been hit with a $750,000 fine for engaging in unconscionable conduct by misleading, harassing and coercing two vulnerable customers while chasing unpaid debts.
Ethicon wants class closure order in pelvic mesh case
Johnson & Johnson unit Ethicon is seeking a class closure order in the pelvic mesh class action, as the company prepares to enter mediation.
Full Court tosses ACCC appeal in Medibank disclosure case
The Australian Competition and Consumer Commission has lost an appeal of a ruling that dismissed its case over allegedly inadequate disclosures by private health insurer Medibank relating to member benefits.
Property spruiker Otton can’t use Bondi estate cash for legal bills, ACCC says
The Australian Competition and Consumer Commission wants to block former We Buy Houses director Rick Otton from using the proceeds from the sale of his $3.6 million Bondi home to help with legal costs and living expenses as he appeals a record $6 million fine for consumer law violations.
IOOF says APRA should be able to state its case after 3-year probe
A barrister for two units of embattled wealth manager IOOF and three senior company executives facing claims by APRA have criticised the regulator for filing a broad concise statement and no statement of claim after a three-year investigation.
Teva files challenge to Boehringer inhaler capsule patent
Generic drug giant Teva has filed a lawsuit seeking to have German pharmaceutical company Boehringer's patent for an inhalation capsule, which is used to deliver the active drug in its blockbuster Spiriva asthma inhaler, declared invalid.
NSW Ports pans ACCC for ‘vague’ competition case
NSW Ports has criticised the Australian Competition and Consumer Commission for expecting the company to file a defence to the regulator's allegations of anti-competitive conduct from a concise statement it panned as "vague".
Sanofi denied injunction in injector pen patent dispute
A judge has denied Sanofi's bid to block Alphapharm from listing its insulin injector pen on the Pharmaceutical Benefit Scheme, saying Sanofi has not established a strong enough case of infringement to justify granting the injunction.
GetSwift class notice delayed as law firm told to get ‘house in order’
A law firm on the losing end of a landmark ruling over competing shareholder class actions against GetSwift has argued that a proposed opt-out notice to group members should wait until after its High Court appeal. And the judge will let the firm make its argument, after hearing that the winning law firm has been, in his words, "sitting on its hands".
Lead applicant socked with costs of Banksia class member’s appeal
The lead applicant in a class action over the failure of Banksia Securities is on the hook for paying the legal costs of a class member who successfully challenged the funder's cut of a $64 million settlement in the case.